JP2010502600A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010502600A5 JP2010502600A5 JP2009526572A JP2009526572A JP2010502600A5 JP 2010502600 A5 JP2010502600 A5 JP 2010502600A5 JP 2009526572 A JP2009526572 A JP 2009526572A JP 2009526572 A JP2009526572 A JP 2009526572A JP 2010502600 A5 JP2010502600 A5 JP 2010502600A5
- Authority
- JP
- Japan
- Prior art keywords
- plasminogen
- use according
- infectious disease
- compound
- domain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US82366506P | 2006-08-28 | 2006-08-28 | |
| US60/823,665 | 2006-08-28 | ||
| PCT/SE2007/050585 WO2008026999A2 (en) | 2006-08-28 | 2007-08-28 | Candidates against infection |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010502600A JP2010502600A (ja) | 2010-01-28 |
| JP2010502600A5 true JP2010502600A5 (cg-RX-API-DMAC7.html) | 2010-09-09 |
| JP5566105B2 JP5566105B2 (ja) | 2014-08-06 |
Family
ID=39136397
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009526572A Expired - Fee Related JP5566105B2 (ja) | 2006-08-28 | 2007-08-28 | 感染症に対する候補薬 |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US8318661B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2056864B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5566105B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR101517626B1 (cg-RX-API-DMAC7.html) |
| CN (2) | CN101573134B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2007290881B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2662101C (cg-RX-API-DMAC7.html) |
| DK (1) | DK2056864T3 (cg-RX-API-DMAC7.html) |
| EA (1) | EA016250B1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2451015T3 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2009002226A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2008026999A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8501198B2 (en) | 2004-06-07 | 2013-08-06 | Qu Biologics Inc. | Tissue targeted antigenic activation of the immune response to treat cancers |
| US9107864B2 (en) | 2004-06-07 | 2015-08-18 | Qu Biologics Inc. | Tissue targeted antigenic activation of the immune response to treat cancers |
| AU2007290882B2 (en) | 2006-08-28 | 2013-02-21 | Omnio Healer Ab | Novel drug target of preventing and treating periodontal disease, improving healing of periodontal wounds and promoting oral health |
| NZ597452A (en) | 2009-07-10 | 2013-10-25 | Thrombogenics Nv | Variants of plasminogen and plasmin |
| WO2011023805A1 (en) | 2009-08-28 | 2011-03-03 | Thrombogenics N.V. | Use of plasmin for the treatment of filtration failure after trabeculectomy |
| RU2421192C1 (ru) * | 2010-03-09 | 2011-06-20 | Винера Гумаровна Нафикова | Способ лечения хронического бактериального конъюнктивита |
| PL2598165T3 (pl) * | 2010-07-26 | 2018-02-28 | Qu Biologics Inc. | Immunogenne kompozycje przeciwzapalne |
| CA2823491A1 (en) | 2011-01-05 | 2012-07-12 | Thrombogenics Nv | Plasminogen and plasmin variants |
| CA2844644A1 (en) | 2011-08-12 | 2013-02-21 | Thrombogenics N.V. | Plasminogen and plasmin variants |
| CN102507707B (zh) * | 2011-10-12 | 2015-10-21 | 山东大学 | 一种检测龈沟液中蛋白裂解酶含量的方法 |
| CN106456740B (zh) | 2014-05-02 | 2021-06-08 | Qu生物制药公司 | 抗微生物免疫调节 |
| TWI801331B (zh) * | 2015-11-03 | 2023-05-11 | 美商波麥堤克生物治療股份有限公司 | 纖維蛋白溶酶原缺乏症之纖維蛋白溶酶原替代療法 |
| CN106890321A (zh) * | 2015-12-18 | 2017-06-27 | 深圳瑞健生命科学研究院有限公司 | 一种用于预防和治疗宫颈糜烂的方法 |
| EP3395355B1 (en) * | 2015-12-18 | 2026-03-04 | Talengen International Limited | Plasminogen for use in treating cervical erosion |
| EP3395354B1 (en) * | 2015-12-18 | 2024-05-22 | Talengen International Limited | Plasminogen for use in treating diabetic nephropathy |
| TWI653981B (zh) | 2015-12-18 | 2019-03-21 | 深圳瑞健生命科學硏究院有限公司 | Use of plasminogen for the preparation of a medicament for preventing or treating a condition associated with diabetic nerve injury |
| TWI677347B (zh) * | 2015-12-18 | 2019-11-21 | 大陸商深圳瑞健生命科學研究院有限公司 | 一種預防和治療肝組織損傷及其相關病症的方法 |
| WO2017101871A1 (zh) | 2015-12-18 | 2017-06-22 | 深圳瑞健生命科学研究院有限公司 | 一种预防和治疗心血管病的新方法 |
| JP2019500426A (ja) | 2015-12-18 | 2019-01-10 | タレンゲン インターナショナル リミティッドTalengen International Limited | 糖尿病網膜症を予防または治療するための方法 |
| CA3008466C (en) * | 2015-12-18 | 2023-06-20 | Talengen International Limited | Method for preventing or treating radiation and chemical damage |
| JP7213552B2 (ja) * | 2016-12-15 | 2023-01-27 | タレンゲン インターナショナル リミテッド | 肝の繊維化を予防及び治療するための方法 |
| CN108210904A (zh) * | 2016-12-15 | 2018-06-29 | 深圳瑞健生命科学研究院有限公司 | 治疗动脉粥样硬化及其并发症的药物及其用途 |
| TWI677348B (zh) | 2016-12-15 | 2019-11-21 | 大陸商深圳瑞健生命科學研究院有限公司 | 一種改善心臟病變的方法 |
| WO2018107701A1 (zh) | 2016-12-15 | 2018-06-21 | 深圳瑞健生命科学研究院有限公司 | 一种新的降血糖和提高糖耐量的药物 |
| TWI750189B (zh) | 2016-12-15 | 2021-12-21 | 大陸商深圳瑞健生命科學研究院有限公司 | 一種治療冠狀動脈粥樣硬化及其併發症的方法 |
| CA3047170A1 (en) * | 2016-12-15 | 2018-06-21 | Talengen International Limited | Method for preventing and treating drug-induced renal injury |
| WO2018107689A1 (zh) * | 2016-12-15 | 2018-06-21 | 深圳瑞健生命科学研究院有限公司 | 一种预防和治疗脂质肾损伤的方法 |
| JP7168990B2 (ja) | 2016-12-15 | 2022-11-10 | タレンゲン インターナショナル リミテッド | 肥満症を予防および治療するための方法および薬物 |
| CA3067890A1 (en) | 2017-06-19 | 2018-12-27 | Talengen International Limited | Method for regulating and controling glp-1/glp-1r and drug |
| TWI868051B (zh) * | 2017-06-23 | 2025-01-01 | 美商波麥堤克生物治療股份有限公司 | 與pai-1過表現相關之病狀的纖維蛋白溶酶原治療 |
| CN107496911A (zh) * | 2017-10-20 | 2017-12-22 | 滕敏子 | 一种外科手术后用于防肿胀、抗感染的愈合剂 |
| CN113164564A (zh) * | 2018-11-19 | 2021-07-23 | 诺尔玛克Ip股份有限公司 | 用于治疗或预防心内膜炎的安克洛酶 |
| CN114174528B (zh) * | 2019-08-07 | 2025-02-21 | 学校法人东京齿科大学 | 判别方法、荧光测定装置和检查剂 |
| CN111742887A (zh) * | 2019-12-19 | 2020-10-09 | 广西医科大学第一附属医院 | 放疗后分泌性中耳炎树鼩模型的建立方法 |
| EP4094776A4 (en) * | 2020-02-11 | 2023-05-17 | Talengen International Limited | METHODS AND MEDICATIONS FOR THE TREATMENT OF VIRAL PENMONIA |
| WO2021180068A1 (zh) * | 2020-03-09 | 2021-09-16 | 泰伦基国际有限公司 | 一种治疗2019新型冠状病毒引发疾病的方法和药物 |
| US10973908B1 (en) | 2020-05-14 | 2021-04-13 | David Gordon Bermudes | Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine |
| US12537071B1 (en) | 2020-07-22 | 2026-01-27 | David Gordon Bermudes | Bacteria having boolean control pathways expressing therapeutic proteins including immunotherapeutic cytotoxins |
| CN115845036B (zh) * | 2023-02-20 | 2023-05-09 | 滨州益洁口腔有限公司 | 用于口腔种植体牙龈组织的蛋白酶及制备方法 |
| JP2026526789A (ja) * | 2023-07-20 | 2026-08-10 | カトリック ユニヴェルシテット ルーヴェン | ブドウ球菌性膿瘍の治療 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3023143A (en) * | 1959-10-14 | 1962-02-27 | American Cyanamid Co | Process for preparing a veterinary composition |
| AT402367B (de) * | 1990-10-11 | 1997-04-25 | Immuno Ag | Pharmazeutische zubereitung auf basis von lys-plasminogen |
| US6054122A (en) * | 1990-11-27 | 2000-04-25 | The American National Red Cross | Supplemented and unsupplemented tissue sealants, methods of their production and use |
| US5792835A (en) | 1991-09-05 | 1998-08-11 | Baxter International Inc. | Method of preparing a topical fibrinogen complex |
| US5397578A (en) * | 1994-03-29 | 1995-03-14 | Tovarischestvo S Ogranichennoi Otvetstvennostiju "Taurus" | Method of treatment of chronic purulent inflammations of ear in children |
| US6372473B1 (en) | 1997-05-28 | 2002-04-16 | Human Genome Sciences, Inc. | Tissue plasminogen activator-like protease |
| US6420622B1 (en) * | 1997-08-01 | 2002-07-16 | 3M Innovative Properties Company | Medical article having fluid control film |
| AU5390699A (en) | 1998-07-24 | 2000-02-14 | Pharmacal Biotechnologies, Inc. | Osseous tissue reconstruction system and method |
| WO2000051538A1 (en) | 1999-03-01 | 2000-09-08 | Uab Research Foundation | Porous tissue scaffolding materials and uses thereof |
| US20030026794A1 (en) * | 2001-07-31 | 2003-02-06 | Howard Fein | Selective enzyme treatment of skin conditions |
| US7067492B2 (en) * | 2001-09-06 | 2006-06-27 | Omnio Ab | Method of promoting healing of a tympanic membrane perforation |
| US20030206906A1 (en) | 2001-11-26 | 2003-11-06 | Genentech, Inc. | Catheter composition and uses thereof |
| MXPA04007585A (es) * | 2002-02-06 | 2005-09-20 | N Zyme Biotec Gmbh | Metodo para la produccion de proteinas recombinantes en microorganismos. |
| CN1420126A (zh) | 2002-07-10 | 2003-05-28 | 牛勃 | 一种重组人纤溶酶原Kringle5突变体蛋白rhPK-5的制备方法 |
| AU2007290882B2 (en) | 2006-08-28 | 2013-02-21 | Omnio Healer Ab | Novel drug target of preventing and treating periodontal disease, improving healing of periodontal wounds and promoting oral health |
-
2007
- 2007-08-28 CA CA2662101A patent/CA2662101C/en not_active Expired - Fee Related
- 2007-08-28 US US12/439,517 patent/US8318661B2/en active Active
- 2007-08-28 EA EA200970233A patent/EA016250B1/ru not_active IP Right Cessation
- 2007-08-28 CN CN2007800324051A patent/CN101573134B/zh active Active
- 2007-08-28 AU AU2007290881A patent/AU2007290881B2/en not_active Ceased
- 2007-08-28 EP EP07794195.3A patent/EP2056864B1/en not_active Not-in-force
- 2007-08-28 MX MX2009002226A patent/MX2009002226A/es active IP Right Grant
- 2007-08-28 CN CN200780032092XA patent/CN101563100B/zh not_active Expired - Fee Related
- 2007-08-28 DK DK07794195.3T patent/DK2056864T3/en active
- 2007-08-28 KR KR1020097005738A patent/KR101517626B1/ko not_active Expired - Fee Related
- 2007-08-28 ES ES07794195.3T patent/ES2451015T3/es active Active
- 2007-08-28 WO PCT/SE2007/050585 patent/WO2008026999A2/en not_active Ceased
- 2007-08-28 JP JP2009526572A patent/JP5566105B2/ja not_active Expired - Fee Related
-
2012
- 2012-11-26 US US13/685,466 patent/US20130149321A1/en not_active Abandoned
-
2015
- 2015-12-09 US US14/964,481 patent/US10729750B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011528713A5 (cg-RX-API-DMAC7.html) | ||
| ECSP066314A (es) | Derivados piridilo y su uso como agentes terapéuticos | |
| WO2005011657A3 (en) | Piperazine derivatives and their use as therapeutic agents | |
| EP2368900A3 (en) | Inhibitors of serine proteases, particularly hcv ns3-ns4a protease | |
| ATE509629T1 (de) | Kombination von iap-inhibitoren und flt3- inhibitoren | |
| JP2007501251A5 (cg-RX-API-DMAC7.html) | ||
| WO2006086447A3 (en) | Pyridazine derivatives and their use as therapeutic agents | |
| AR090349A1 (es) | Terapia de combinacion para trastornos proliferativos, kit y uso | |
| JP2016507532A5 (cg-RX-API-DMAC7.html) | ||
| RU2008150615A (ru) | Соединения и композиции в качестве ингибиторов протеазы, активирующей каналы | |
| JP2010539179A5 (cg-RX-API-DMAC7.html) | ||
| MY147643A (en) | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder | |
| CL2012001056A1 (es) | Compuestos derivados de cromenona sustituidos, inhibidores de enzimas pi 3 quinasa; composicion farmaceutica; y uso en el tratamiento o prevencion de trastornos de proliferacion celular, tales como tumores enfermedades inflamatorias y fibroticas, asma, diabetes insulinodependiente, entre otras. | |
| JP2009503024A5 (cg-RX-API-DMAC7.html) | ||
| RU2015132369A (ru) | Комбинированная терапия для лечения нозокомиальной пневмонии | |
| RU2010142456A (ru) | Синергические комбинации 5'-метилтиоаденозина | |
| AR065316A1 (es) | Uso de quitosanos, derivados de quitosanos y una sal fisiologiamente aceptable del mismo para el tratamiento de enfermedades inflamatorias ungueales | |
| AR050463A1 (es) | Analagos de lonidamina y su uso en anticoncepcion masculina y en el tratamiento contra el cancer. | |
| CN112788950A (zh) | 用于治疗伤口的铋-硫醇组合物和方法 | |
| BRPI0413964B8 (pt) | ácido derivado do ácido carboxílico quinolona, sua composição e agente antibacterial | |
| FR2850023B1 (fr) | Medicaments pour le systeme nerveux | |
| AR007021A1 (es) | Derivados de 3-descladinosa-2,3-anhidroeritromicina, procedimientos para su preparacion, compuestos para su exclusivo uso en dichos procedimientosy procedimiento para su preparacion, una composicion farmaceutica para tratar infecciones bacterianas y el uso de estos compuestos para preparar medicamentos | |
| BRPI0418742A (pt) | métodos de tratamento, prevenção ou controle de uma sìndrome mielodisplásica, de redução ou evitação de um efeito adverso associado com a administração de um segundo ingrediente ativo em um paciente sofrendo de um sìndrome mielodisplásica, composição farmacêutica, forma de dosagem unitária única, e, kit | |
| DOP2005000039A (es) | Hidrocloruro de [4-(5-aminometil-2-fluoro-fenil)- piperidin-1-il]-(4-bomo-3-metil-5-propoxi-tiofen-2-il)-metanona como un inhibidor de la triptasa de mastocitos | |
| JP2014504636A5 (cg-RX-API-DMAC7.html) |